. | DMBA treatment . | . | Host age at transplant (weeks) . | No. tumors/No. transplants . | TE50 (weeks) . | |
---|---|---|---|---|---|---|
Group . | Host . | Epithelium . | . | . | . | |
1 | - | - | 3 | 11/17 | 44 | |
2 | + | + | 3 | 16/17 | 17† | |
3 | - | - | 11 | 13/16 | 41 | |
4 | + | - | 11 | 8/16 | 45 | |
5 | - | + | 11 | 9/10 | 35 | |
6 | + | + | 11 | 11/12 | 32 | |
7 | - | - | 12 | 14/16 | 38 | |
8 | +(MFP)‡ | - | 12 | 13/16 | 38 |
. | DMBA treatment . | . | Host age at transplant (weeks) . | No. tumors/No. transplants . | TE50 (weeks) . | |
---|---|---|---|---|---|---|
Group . | Host . | Epithelium . | . | . | . | |
1 | - | - | 3 | 11/17 | 44 | |
2 | + | + | 3 | 16/17 | 17† | |
3 | - | - | 11 | 13/16 | 41 | |
4 | + | - | 11 | 8/16 | 45 | |
5 | - | + | 11 | 9/10 | 35 | |
6 | + | + | 11 | 11/12 | 32 | |
7 | - | - | 12 | 14/16 | 38 | |
8 | +(MFP)‡ | - | 12 | 13/16 | 38 |
P<0.05 compared with group 1. ‡MFP, mammary fat pad.